Aldo Trylesinski

Aldo Trylesinski has extensive work experience in the pharmaceutical industry, with a focus on medical roles. Aldo is currently serving as the Executive Medical Director Hepatology and Speciality Medicines at Advanz Pharma since July 2022. Prior to that, they held the position of Executive Medical Director and Regional Medical Director at Interceptpharma from 2015 to 2022. Before joining Interceptpharma, Trylesinski worked at Novartis Pharma AG, where they held various positions, including Senior Global Brand Medical Director and Global Brand Medical Director, specializing in Hepatitis treatment and Anti-infectives. Aldo also served as a Principal Medical Scientific Expert. Trylesinski began their career as an Affiliate Physician in Internal Medicine at the Institute Alfred Fournier in Paris, France. Aldo also worked as an Affiliate Physician at G.Pompidou European Hospital, focusing on HIV, Metabolism, and Nutrition. Additionally, Trylesinski served as an Associate Medical Director on Virology at Gilead Sciences. Aldo has experience as a Medical Manager at Roche Pharmaceuticals and Hoffmann-La Roche. Trylesinski started their educational journey at Universidad Peruana Cayetano Heredia in Peru.

Aldo Trylesinski obtained their Doctor of Medicine degree from Universidad Peruana Cayetano Heredia in 1982. Aldo pursued their field of study in Gastroenterology at Pierre and Marie Curie University from 1984 to 1988. Later, in 1992 and 1996, they completed Post-Docs in the fields of Post-AIDS & Retroviruses and Nutrition at Université Paris Cité, respectively. In 2001, they received a Board Certification in Internal Medicine from the French Board Qualification.